Safety of High Dose Erythropoietin Used with Therapeutic Hypothermia as Treatment for Newborn Hypoxic-Ischemic Encephalopathy: Secondary Analysis of the HEAL Randomized Controlled Trial
Authors:
- 4 April 2023
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 258, 113400
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (1U01NS092764, U01NS092553)
This publication has 25 references indexed in Scilit:
- Implementation and Conduct of Therapeutic Hypothermia for Perinatal Asphyxial Encephalopathy in the UK – Analysis of National DataPLOS ONE, 2012
- Systemic Hypothermia After Neonatal Encephalopathy: Outcomes of neo.nEURO.network RCTPediatrics, 2010
- Thrombotic Complications of Erythropoiesis-Stimulating AgentsSeminars in Thrombosis and Hemostasis, 2010
- Human Recombinant Erythropoietin in Asphyxia Neonatorum: Pilot TrialPediatrics, 2010
- Erythropoietin Improved Neurologic Outcomes in Newborns With Hypoxic-Ischemic EncephalopathyPediatrics, 2009
- Treatment of asphyxiated newborns with moderate hypothermia in routine clinical practice: how cooling is managed in the UK outside a clinical trialArchives of Disease in Childhood - Fetal and Neonatal Edition, 2008
- The TOBY Study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: A randomised controlled trialBMC Pediatrics, 2008
- Erythropoietin after a century of research: younger than everEuropean Journal of Haematology, 2007
- Whole-Body Hypothermia for Neonates with Hypoxic–Ischemic EncephalopathyNew England Journal of Medicine, 2005
- The decision to prematurely terminate a trial of R-HuEPO due to thrombotic eventsJournal of Pain and Symptom Management, 2004